|
1
|
Boutin C, Schlesser M, Frenay C and Astoul
P: Malignant pleural mesothelioma. Eur Respir J. 12:972–981.
1988.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sugarbaker DJ and Norberto JJ:
Multimodality management of malignant pleural mesothelioma. Chest.
113 (Suppl 1):S61–S65. 1988.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wagner JC, Sleggs CA and Marchand P:
Diffuse pleural mesothelioma and asbestos exposure in the North
Western Cape Province. Br J Ind Med. 17:260–271. 1960.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hanna L and Macbeth F: Mesothelioma. In:
Practical Clinical Oncology. Hanna L, Crosby T and Macbeth F (eds).
1st edition. Cambridge University Press: Cambridge, New York,
pp328-333, 978-0-521-61816-8, 2008.
|
|
5
|
Galateau-Salle F, Brambilla E and Cagle
PT: Clinical aspects of mesothelioma. In: Pathology of Malignant
Mesothelioma. Galateau-Salle F (ed). Springer, London, pp31-39,
978-1-84628-012-2, 2006.
|
|
6
|
Law MR, Hodson ME and Heard BE: Malignant
mesothelioma of the pleura: Relation between histological type and
clinical behaviour. Thorax. 37:810–815. 1982.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hesterberg TW and Barrett JC: Induction by
asbestos fibers of anaphase abnormalities: Mechanism for aneuploidy
induction and possibly carcinogenesis. Carcinogenesis. 6:473–475.
1985.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cheng JQ, Lee WC, Klein MA, Cheng GZ,
Jhanwar SC and Testa JR: Frequent mutations of NF2 and allelic loss
from chromosome band 22q12 in malignant mesothelioma: Evidence for
a two-hit mechanism of NF2 inactivation. Genes Chromosomes Cancer.
24:238–242. 1999.PubMed/NCBI
|
|
9
|
Cote RJ, Jhanwar SC, Novick S and Pellicer
A: Genetic alterations of the p53 gene are a feature of malignant
mesotheliomas. Cancer Res. 51:5410–5416. 1991.PubMed/NCBI
|
|
10
|
Zucali PA, Ceresoli GL, De Vincenzo F,
Simonelli M, Lorenzi E, Gianoncelli L and Santoro A: Advances in
the biology of malignant pleural mesothelioma. Cancer Treat Rev.
37:543–58. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Papp T, Schipper H, Pemsel H, Bastrop R,
Muller KM, Wiethege T, Weiss DG, Dopp E, Schiffmann D and Rahman Q:
Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes
in primary human malignant mesotheliomas. Int J Oncol. 18:425–433.
2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yang H, Bocchetta M, Kroczynska B,
Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa
JR, et al: TNF-alpha inhibits asbestos induced cytotoxicity via a
NF-kappaB-dependent pathway, a possible mechanism for
asbestos-induced oncogenesis. Proc Natl Acad Sci USA.
103:10397–10402. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cicala C, Pompetti F and Carbone M: SV40
induces mesotheliomas in hamsters. Am J Pathol. 142:1524–1534.
1993.PubMed/NCBI
|
|
14
|
Jasani BI and Gibbs A: Mesothelioma not
associated with asbestos exposure. Arch Pathol Lab Med. 136:262–7.
2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cavazza A, Travis LB, Travis WD, Wolfe JT
III, Foo ML, Gillespie DJ, Weidner N and Colby TV: Post-irradiation
malignant mesothelioma. Cancer. 77:1379–1385. 1996.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Carbone M, Ly BH, Dodson RF, Pagano I,
Morris PT, Dogan UA, Gazdar AF, Pass HI and Yang H: Malignant
mesothelioma: Facts, myths, and hypotheses. J Cell Physiol.
227:44–58. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bueno R, Stawiski EW, Goldstein LD,
Durinck S, De Rienzo A, Modrusan Z, Gnad F, Nguyen TT, Jaiswal BS,
Chirieac LR, et al: Comprehensive genomic analysis of malignant
pleural mesothelioma identifies recurrent mutations, gene fusions
and splicing alterations. Nat Genet. 48:407–416. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Goldberg M, Imbernon E, Rolland P, Gilg
Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming's S, Arveux
P, Boutin C, et al: The French National Mesothelioma Surveillance
Program. Occup Environ Med. 63:390–395. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Carbone M, Shimizu D, Napolitano A, Tanji
M, Pass H, Yang H and Pastorino S: Positive nuclear BAP1
immunostaining helps differentiate nonsmall cell lung carcinomas
from malignant mesothelioma. Oncotarget. 7:59314–59321.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guo Z, Carbone M, Zhang X, Su D, Sun W,
Lou J, Gao Z, Shao D, Chen J, Zhang G, et al: Improving the
Accuracy of Mesothelioma Diagnosis in China. J Thorac Oncol.
12:714–723. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
King JE, Thatcher N, Pickering CAC and
Hasleton PS: Sensitivity and specificity of immunohistochemical
markers used in the diagnosis of epithelioid mesothelioma: A
detailed systematic analysis using published data. Histopathology.
48:223–232. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kato Y, Tsuta K, Seki K, Maeshima AM,
Watanabe S, Suzuki K, Asamura H, Tsuchiya R and Matsuno Y:
Immunohistochemical detection of GLUT1 can discriminate between
reactive mesothelium and malignant mesothelioma. Mod Pathol.
20:215–220. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brenner J, Sordillo PP, Magill GB and
Golbey RB: Malignant mesothelioma of the pleura: review of 123
patients. Cancer. 49:2431–2435. 1982.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Husain AN, Colby TV, Ordóñez NG, Krausz T,
Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs
AR, et al: Guidelines for pathologic diagnosis of malignant
mesothelioma: A consensus statement from the International
Mesothelioma Interest Group. Arch Pathol Lab Med. 133:1317–1331.
2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Galateau-Salle F, Brambilla E and Cagle
PT: Classification and histologic features of epithelioid
mesotheliomas. In: Pathology of Malignant Mesothelioma.
Galateau-Salle F (ed). Springer, London, pp68-131,
978-1-84628-012-2, 2006.
|
|
26
|
Doglioni C, Dei Tos AP, Laurino L,
Iuzzolino P, Chiarelli C, Celio MR and Viale G: Calretenin: A novel
immunocytochemical marker for mesothelioma. Am J Surg Pathol.
20:1037–1046. 1996.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Marchevsky AM: Application of
immunohistochemistry to the diagnosis of malignant mesothelioma.
Arch Pathol Lab Med. 132:397–401. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pass HI and Carbone M: Current status of
screening for malignant pleural mesothelioma. Semin Thorac
Cardiovasc Surg. 21:97–104. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ray M and Kindler HL: Malignant pleural
mesothelioma: an update on biomarkers and treatment. Chest.
136:888–896. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kerpel SM and Freedman PD: Metastatic
mesothelioma of the oral cavity. Oral Surg Oral Med Oral Pathol.
76:746–751. 1993.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sproat CP, Brown AE and Lindley RP: Oral
metastasis in malignant pleural mesothelioma. Br J Oral Maxillofac
Surg. 31:316–317. 1993.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Piattelli A, Fioroni M and Rubini C:
Tongue metastasis from a malignant diffuse mesothelioma of the
pleura: Report of a case. J Oral Maxillofac Surg. 57:861–863.
1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Garcia-Reija MF, Matilla JM, De Paz A,
Sanchez-Cuellar A and Verrier A: Unusual metastasis to the
mandibular alveolus of malignant pleural mesothelioma. Otolaryngol
Head Neck Surg. 126:435–437. 2002.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cassarino DS, Xue W and Shannon KJ:
Widespread cutaneous and perioral metastases of mesothelioma. J
Cutan Pathol. 30:582–585. 2003.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zanconati F, Delconte A, Bonifacio-Gori D
and Falconieri G: Metastatic pleural mesothelioma presenting with
solitary involvement of the tongue: Report of a new case and review
of the literature. Int J Surg Pathol. 11:51–55. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Soyuer I, Soyuer S, Canöz Ö, Coşkun S and
Balkanli S, kun S and Balkanli S: Three patients with unusual
metastases. Cytopathology. 15:58–62. 2004.
|
|
37
|
Terakado N, Shintani S, Nakashiro K and
Hamakawa H: Malignant pleural mesothelioma metastasis to the
mandible. Int J Oral Maxillofac Surg. 33:789–800. 2004.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tho LM and O'Rouke NP: Unusual metastases
from malignant pleural mesothelioma. Clin Oncol (R Coll Radiol).
17(293)2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Higginson DS, Brahmer J, Tufano RP and
Bajaj GK: Pleural mesothelioma metastatic to the tongue. J Clin
Oncol. 25:2133–2135. 2007.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hashitani S, Sakurai K, Takaoka K and
Urade M: Metastatic malignant pleural mesothelioma of the tongue:
Report of a case. Brit J Oral Maxillofac Surg.
47(247)2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kirke D, Horwood K and Wallwork B: Floor
of mouth and tongue metastasis from malignant pleural mesothelioma.
ANZ J Surg. 80:556–558. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Murray LJ, Higham J, Suvarna SK, Craig GT,
Bridgewater CH, Fisher PM and Thornhill MH: Oral presentation of
malignant mesothelioma. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 111:e21–e26. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sinon SH, Rich AM, Hussaini HM, Yoon HS,
Firth NA and Seymour GJ: Metastases to the oral region from pleural
mesothelioma: Clinicopathologic review. Head Neck. 35:599–604.
2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Billè A, Platania M, Pelosi G, Padovano B,
Quattrone P and Pastorino U: Gingival metastasis as first sign of
multiorgan dissemination of epithelioid malignant mesothelioma. J
Thorac Oncol. 9:1226–1229. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Arslan A, Ozcakir-Tomruk C, Deniz E and
Akin O: A case report of metastasis of malignant mesothelioma to
the retromolar trigone. World J Surg Oncol. 14(188)2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ohnishi Y, Sugitatsu M, Watanabe M, Fujii
T and Kakudo K: Metastasis of mesothelioma to the maxillary
gingiva. Oncol Lett. 8:1214–1216. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Moser S, Beer M, Damerau G, Lubbers HT,
Gratz KW and Kruse AL: A case report of metastasis of malignant
mesothelioma to the oral gingiva. Head Neck Oncol.
3(21)2011.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sawaki K, Okazaki F, Sato A, Najano M,
Takagi S and Iida S: A case of malignant pleural mesothelioma with
metastasis to the upper jaw. Japanese J Oral Maxillofac Surg.
61:168–172. 2015.
|
|
49
|
Vazquez MV, Selvendran S, Cheluvappa R and
McKay MJ: Peritoneal mesothelioma metastasis to the
tongue-comparison with 8 pleural mesothelioma reports with tongue
metastasis. Ann Med Surg (Lond). 5:101–105. 2016.
|
|
50
|
Tanaka T, Nakamatsu K and Imamura T:
Metastasis of malignant pleural mesothelioma to maxillary gingiva:
A case report and literature review. J Oral Maxillofac Surg Med
Pathol. 32:140–144. 2020.
|
|
51
|
Spirtas R, Heineman EF, Bernstein L, Beebe
GW, Keehn RJ, Stark A, Harlow BL and Benichou J: Malignant
mesothelioma: attributable risk of asbestos exposure. Occup Environ
Med. 51:804–811. 1994.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Baumann F, Ambrosi JP and Carbone M:
Asbestos is not just asbestos: An unrecognised health hazard.
Lancet Oncol. 14:576–578. 2013.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Carbone M, Baris YI, Bertino P, Brass B,
Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR,
et al: Erionite exposure in North Dakota and Turkish villages with
mesothelioma. Proc Natl Acad Sci USA. 108:13618–13623.
2011.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Hillegass JM, Shukla A, Lathrop SA,
MacPherson MB, Beuschel SL, Butnor KJ, Testa JR, Pass HI, Carbone
M, Steele C and Mossman BT: Inflammation precedes the development
of human malignant mesotheliomas in a SCID mouse xenograft model.
Ann N Y Acad Sci. 1203:7–14. 2010.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Yang H, Rivera Z, Jube S, Nasu M, Bertino
P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, et al:
Programmed necrosis induced by asbestos in human mesothelial cells
causes high mobility group box 1 protein release and resultant
inflammation. Proc Natl Acad Sci USA. 107:12611–12616.
2010.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Carbone M and Yang H: Molecular pathways:
Targeting mechanisms of asbestos and erionite carcinogenesis in
mesothelioma. Clin Cancer Res. 18:598–604. 2012.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Napolitano A, Antoine DJ, Pellegrini L,
Baumann F, Pagano I, Pastorino S, Goparaju CM, Prokrym K, Canino C,
Pass HI, et al: HMGB1 and its hyperacetylated isoform are sensitive
and specific serum biomarkers to detect asbestos exposure and to
identify mesothelioma patients. Clin Cancer Res. 22:3087–3096.
2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Carbone M, Emri S, Dogan AU, Steele I,
Tuncer M, Pass HI and Baris YI: A mesothelioma epidemic in
Cappadocia: Scientific developments and unexpected social outcomes.
Nat Rev Cancer. 7:147–154. 2007.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Dogan AU, Baris YI, Dogan M, Emri S,
Steele I, Elmishad AG and Carbone M: Genetic predisposition to
fiber carcinogenesis causes a mesothelioma epidemic in Turkey.
Cancer Res. 66:5063–5068. 2006.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Testa JR, Cheung M, Pei J, Krausz T, Testa
JR and Gaudino G: Germline BAP1 mutations predispose to malignant
mesothelioma. Nat Genet. 43:1022–1025. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
61
|
Carbone M, Yang H, Pass HI, Krausz T,
Testa JR and Gaudino G: BAP1 and cancer. Nat Rev Cancer.
13:153–159. 2013.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Nasu M, Emi M, Pastorino S, Tanji M,
Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, et al:
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant
Mesothelioma. J Thorac Oncol. 10:565–576. 2015.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Mori T, Sumii M, Fujishima F, Ueno K, Emi
M, Nagasaki M, Ishioka C and Chiba N: Somatic alteration and
depleted nuclear expression of BAP1 in human esophageal squamous
cell carcinoma. Cancer Sci. 106:1118–1129. 2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Yoshikawa Y, Emi M, Hashimoto-Tamaoki T,
Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M,
Pastorino S, et al: High density array-CGH with targeted NGS unmask
multiple noncontiguous minute deletions on chromosome 3p21 in
mesothelioma. Proc Natl Acad Sci USA. 113:13432–13437.
2016.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Cutrone R, Lednicky J, Dunn G, Rizzo P,
Bocchetta M, Chumakov K, Minor P and Carbone M: Some oral
poliovirus vaccines were contaminated with infectious SV40 after
1961. Cancer Res. 65:10273–10279. 2005.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Qi F, Carbone M, Yang H and Gaudino G:
Simian virus 40 transformation, malignant mesothelioma and brain
tumors. Expert Rev Respir Med. 5:683–697. 2011.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Bocchetta M, Eliasz S, De Marco MA,
Rudzinski J, Zhang L and Carbone M: The SV40 large T antigen-p53
complexes bind and activate the insulin-like growth factor-I
promoter stimulating cell growth. Cancer Res. 68:1022–1029.
2008.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Banaei A, Auvert B, Goldberg M, Gueguen A,
Luce D and Goldberg S: Future trends in mortality of French men
from mesothelioma. Occup Environ Med. 57:488–494. 2000.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Leigh J, Davidson P, Hendrie L and Berry
D: Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med.
41:188–201. 2002.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Price B: Analysis of current trends in
United States mesothelioma incidence. Am J Epidemiol. 145:211–218.
1997.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Robinson BW and Lake RA: Advances in
malignant mesothelioma. N Engl J Med. 353:1591–1603.
2005.PubMed/NCBI View Article : Google Scholar
|
